Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis
Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis: Study Protocol for a Double-blind, Randomized, Parallel-group, Multi-center Trial
Sponsor: DongGuk University
A PHASE3 clinical study on Perennial Allergic Rhinitis, this trial is ongoing. The trial is conducted by DongGuk University and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Apr 2019 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE3
-
Feb 2018 — Jun 2018 [monthly]
Recruiting PHASE3
-
Apr 2017 — Feb 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Apr 2017 [monthly]
Recruiting PHASE3
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- DongGuk University
- Kyung Hee University Hospital
- Kyung Hee University Hospital at Gangdong
- Pusan National University Hospital
- Semyung University Affiliated Oriental Medical Hospital
For direct contact, visit the study record on ClinicalTrials.gov .